Skip to content

Roivant Sciences ROIV Ratios & Valuation

Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24
Profitability
Free cash flow margin-9,183.5%-6,278pp-5,761.5%-3,206pp-3,858.4%-1,750pp-3,695.9%-1,735pp-2,905.2%-1,367pp
Efficiency
Asset turnover0.0×0.0×0.0×0.0×0.0×
Liquidity
Current ratio18.4×-15.1×30.7×-7.2×33.7×+23.3×40.5×+12.6×33.5×+8.2×
Quick ratio18.4×-15.1×30.7×-7.2×33.7×+23.3×40.5×+12.8×33.5×+8.4×
Cash ratio+4.4×0.6×-0.1×0.8×+0.5×0.8×-25.6×0.6×-0.1×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×-0.1×
Debt-to-assets0.0×0.0×0.0×0.0×-0.1×
Per Share
Book value per share$6.52+1.0%$6.13-14.7%$6.41-8.6%$6.39-8.1%$6.46-10.0%
Valuation
Market capitalization$19.82B+175%$15.09B+75.3%$10.33B+21.7%$7.84B+0.9%$7.2B-14.9%
Enterprise value$18.51B+157%$15.11B+75.4%$10.33B+22.7%$7.85B+219%$7.21B-17.9%
Price / sales2,400.1×+2,152×1,133.9×+852×508.2×+279×337.7×+123×247.8×+78.1×
Price / book4.4×+2.8×3.5×+1.9×2.4×+0.7×1.8×+0.4×1.5×+0.1×
EV / sales2,241.3×+1,993×1,135.2×+853×508.1×+281×337.9×+270×248×+71.9×
Free cash flow yield-3.8%+7.9pp-5.1%+4.0pp-7.6%+1.6pp-10.9%-1.8pp-11.7%-2.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Roivant Sciences's ratios come from?
Every ratio is computed from Roivant Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.